Mefloquine labels and packages
| Mefloquine |
|---|
| MEFLOQUINE HYDROCHLORIDE® FDA Package Insert |
| Description |
| Clinical Pharmacology |
| Microbiology |
| Indications and Usage |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Drug Interactions |
| Overdosage |
| Dosage and Administration |
| How Supplied |
| Labels and Packages |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Labels And Packages
Labels And Packages
TEVA PHARMACEUTICALS USA
Sellersville, PA 18960
Rev. B 6/2013
PRINCIPAL DISPLAY PANEL[1]
| [[File:|800px|thumb]] |
Mefloquine HCl Tablets USP 250mg 25s Carton Text
NDC 0555-0171-78
MEFLOQUINE HCl Tablets USP 250 mg
Each tablet contains 250 mg mefloquine hydrochloride USP.
PHARMACIST: Dispense the enclosed Medication Guide to each patient.
Rx only
25 UNIT-DOSE TABLETS (5 x 5)
TEVA
References
References
Adapted from the FDA Package Insert.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH